Bile and unsaturated fatty acids inhibit the binding of cholera toxin and Escherichia coli heat-labile enterotoxin to GM1 receptor

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 1, 2008, Pages 220-224

  Chatterjee, Arpita ^a   Chowdhury, Rukhsana ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; BILE ACID; CHOLERA TOXIN; ESCHERICHIA COLI ENTEROTOXIN; GANGLIOSIDE GM1; LINOLEIC ACID; OLEIC ACID; UNSATURATED FATTY ACID;

ARTICLE; BILE; ESCHERICHIA COLI; FLUORESCENCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION; TOXIN ANALYSIS;

ANIMALS; BACTERIAL TOXINS; BILE; BINDING SITES; CHOLERA TOXIN; ENTEROTOXINS; ESCHERICHIA COLI PROTEINS; FATTY ACIDS, UNSATURATED; G(M1) GANGLIOSIDE; ILEUM; RABBITS; RECEPTORS, CELL SURFACE;

EID: 37849032036     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01009-07     Document Type: Article

References (17)

1. Ash, R. J., B. Mauck, and M. Morgan. 2002. Antibiotic resistance of gram-negative bacteria in rivers, United States. Emerg. Infect. Dis. 8:713-716.
2. Bhan, M. K., E. Chea Woo, O. Fontaine, I. Maulen-Radovan, N. F. Pierce, and H. Ribeiro, Jr. 1995. Multicentre evaluation of reduced-osmolarity oral rehydration salt solution. Lancet 345:282-285.
3. Chatterjee, A., P. K. Dutta, and R. Chowdhury. 2007. Effect of fatty acids and cholesterol present in bile on expression of virulence factors and motility of Vibrio cholerae. Infect. Immun. 75:1946-1953.
4. Dallas, W. S., and S. Falkow. 1980. Amino acid sequence homology between cholera toxin and Escherichia coli heat-labile toxin. Nature 288:499-501.
5. De, S. N., and S. N. Chatterjee. 1953. An experimental study of the mechanisms of action of Vibrio cholerae on the intestinal mucous membrane. J. Pathol. Bacteriol. 46:559-562.
6. Finkelstein, R. A., M. Boesman, S. H. Neoh, M. K. LaRue, and R. Delaney. 1974. Dissociation and recombination of the subunits of the cholera enterotoxin (choleragen). J. Immunol. 113:145-150.
7. Fishman, P. H. 1990. Mechanism of action of choleratoxin, p. 127-140. In J. Moss and M. Vaughan (ed.), ADP-ribosylating toxins and G proteins. American Society for Microbiology, Washington, DC.
8. Ganguly, N. K., and T. Kaur. 1996. Mechanism of action of cholera toxin & other toxins. Indian J. Med. Res. 104:28-37.
9. Gilligan, P. H., J. C. Brown, and D. C. Robertson. 1983. Immunological relationships between cholera toxin and Escherichia coli heat-labile enterotoxin. Infect. Immun. 42:683-691.
10. Hénock Blaise, N. Y., and D. B. Dovie. 2007. Diarrheal diseases in the history of public health. Arch. Med. Res. 38:159-163.
11. Kabir, S. 1986. Charge heterogeneity of cholera toxin and its subunits. FEMS Microbiol. Lett. 37:155-162.
12. King, C. A., and W. E. Van Heyningen. 1973. Deactivation of cholera toxin by a sialidase-resistant monosialosylganglioside. J. Infect. Dis. 127:639-647.
13. Krishnan, H. H., A. Ghosh., K. Paul, and R. Chowdhury. 2004. Effect of anaerobiosis on expression of virulence factors in Vibrio cholerae. Infect. Immun. 72:3961-3967.
14. Minke, W. E., C. Roach, W. J. Hol, and C. M. J. Verlinde. 1999. Structure based exploration of the ganglioside GM1 binding sites of Escherichia coli heat-labile enterotoxin and cholera toxin for the discovery of receptor antagonists. Biochemistry 38:5684-5692.
15. Mitchell, D. D., J. C. Pickens, K. Korotkov, E. Fan, and W. J. Hol. 2004. 3,5-Substituted phenyl galactosides as leads in designing effective cholera toxin antagonists; synthesis and crystallographic studies. Bioorg. Med. Chem. 12:907-920.
16. Mwansa, J. C., J. Mwaba, C. Lukwesa, N. A. Bhuiyan, M. Ansaruzamman, T. Ramamurthy, M. Alam, and G. B. Nair. 2006. Multiply antibiotic-resistant Vibrio cholerae O1 biotype El Tor strains emerge during cholera outbreaks in Zambia. Epidemiol. Infect. 23:1-7.
17. Rudnick, D. A., C. A. McWherter, S. P. Adams, I. J. Ropson, R. J. Duronio, and J. I. Gordon. 1990. Structural and functional studies of Saccharomyces cerevisiae myristoyl-CoA:protein N-myristoyltransferase produced in Escherichia coli. Evidence for an acyl-enzyme intermediate. J. Biol. Chem. 265:13370-13378.